Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Compounders Complain They Can’t Make These Four Drugs Once They’re Deemed Biologics
Mar 09 2020
•
By
Joanne S. Eglovitch
FDA's Announcement To Shift Four Drug Substances Over To Biologics Raising Resistance • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance